RadNet, Inc.

RDNT Healthcare Diagnostics & Research

RadNet, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.0 billion, up 11.5% from fiscal 2024.

Revenue
+25.0%
EPS
−47.4%
Free cash flow
−43.2%
Total debt
+21.2%

Quarter to June 2026, against a year earlier

75.66 2.35 −3.01%
Market cap
$6.1B
P/E
0.0×
Fwd P/E
1,050×
Dividend yield
—
F-score
3/9
Altman Z
2.04
Beneish M
−2.62
Dividend safety
n/a

RadNet, Inc. (RDNT) Business Profile

Updated · Covers results through FY2025 · How this is made

What it does

RadNet provides outpatient diagnostic imaging services in the United States. Its centers perform scans that help physicians diagnose and treat medical conditions, including MRI, CT, PET, mammography, ultrasound and X-rays. Patients generally come to the centers after a physician refers them for a test. RadNet has been in business since 1985, and Howard G. Berger, M.D. is its president and chief executive officer.

The company operates centers directly and through joint ventures with hospitals and health systems. Most of its centers offer several types of scans, so patients and referring physicians can use one location for different procedures. Radiologists interpret the images: RadNet contracts with medical groups to provide those professional services, while it supplies equipment, technical services and administrative support.

RadNet also sells software through its Digital Health business, led by its DeepHealth subsidiary. Its products help imaging providers manage scheduling, store and retrieve images, coordinate workflows and support radiologists interpreting scans. The portfolio includes artificial intelligence tools for clinical applications such as breast, lung and prostate imaging. RadNet uses these products in its own centers as well as selling them to other organizations.

Outside the United States, a RadNet subsidiary provides remote image interpretation for providers within the United Kingdom’s National Health Service. RadNet has also agreed to acquire ONRAD, a U.S. teleradiology provider; the transaction is expected to close in early 2027, subject to regulatory review and customary closing conditions.

How it makes money

RadNet reports two operating segments: Imaging Centers and Digital Health. For the second quarter of 2026, total company revenue was $622.7 million and adjusted EBITDA was $99.7 million. An annual revenue total for 2025 is not provided here.

The imaging business earns fees for diagnostic procedures. Commercial insurers generally reimburse at negotiated rates, which can differ from Medicare rates, and patients may owe deductibles or co-payments. Government programs, including Medicare and Medicaid, also pay for covered services. Under certain managed-care arrangements, a payor pays a predetermined amount per member per month in exchange for covered radiology services; these arrangements transfer much of the risk of higher use to the radiology practice and, through its management agreement, to RadNet.

RadNet supplies equipment and technical and management services to contracted medical groups. In return, it receives technical fees and an agreed percentage of the practices’ billings or collections for services at its centers. The medical groups retain professional reimbursements after management fees. RadNet also earns fixed or variable management fees for services such as billing, collections and medical coding for some professional groups serving hospitals.

Digital Health sells and licenses imaging software and AI solutions to outside customers as well as providing them to RadNet. Recurring contract value can include subscription fees, support fees and contracted usage charges; one-time implementation, hardware, consulting and training fees are excluded from its annual recurring revenue measure. Digital Health revenue was $32.4 million for the second quarter of 2026. The company reported $105.5 million of annual recurring revenue at quarter-end, a contract metric rather than a forecast of future revenue.

Customers and how it sells

Patients use RadNet’s centers for imaging, often following a referral from a physician. The company maintains relationships with referring physicians, radiology groups and payors in its regional markets. Its payors include commercial insurers, managed-care organizations and government programs; patients can also be responsible for deductibles or co-payments.

As of December 31, 2025, RadNet operated 418 centers in Arizona, California, Delaware, Florida, Maryland, Virginia, New Jersey, Texas and New York. At the end of the second quarter of 2026, it had 442 centers, including 157 held within health-system partnerships. RadNet also announced a joint venture in Boise, Idaho, with Trinity Health’s St. Alphonsus Health System, initially covering five outpatient imaging centers.

Digital Health serves RadNet and outside organizations, including hospital and outpatient imaging customers. Its customer base had reached nearly 3,000 accounts by the second quarter of 2026. In the United Kingdom, RadNet provides remote image interpretation within the National Health Service framework, while its CIMAR business provides image-exchange services to NHS hospitals and private healthcare providers.

During the year ended December 31, 2025, approximately 23.4% of net service revenue generated at RadNet’s diagnostic imaging centers came from Medicare and 2.5% from Medicaid. The company also works with hospitals and health systems as joint-venture partners, rather than only as customers or referral sources.

Suppliers and costs

RadNet obtains major imaging equipment directly from manufacturers or through financing companies and purchases medical supplies from national vendors. Equipment purchase or financing relationships include GE, Hologic, Key Equipment, Philips, Siemens and Spectrum. RadNet seeks relationships with multiple equipment providers to reduce the risk that one becomes unavailable, and it uses manufacturers’ service organizations to maintain equipment.

The company operates in a capital-intensive industry with high fixed costs. It invests in imaging facilities, equipment and technology, including AI, and may take on equipment lease obligations when opening or acquiring centers. RadNet also contracts with medical groups for professional services and provides non-medical staff and administrative support at its centers. It had 11,264 employees in FY2025.

RadNet has reported salary pressure associated with shortages of technologists and radiologists. It also incurs implementation and staff-training costs when introducing Digital Health tools across its operations. Equipment upgrades and remote technologist support are among the ways the company seeks to increase the capacity of existing centers.

From revenue to operating income, FY2025
  1. Revenue$2.0B
  2. Cost of revenue−$1.8B
  3. Other operating costs−$173.5M
  4. Operating income$62.0M

Competitive position

RadNet competes with independent and smaller regional imaging operators, hospitals and hospital groups with their own imaging services, and physician practices that operate imaging centers. Some competitors may have access to greater financial resources, allowing them to establish centers or acquire newer equipment. No competing company is named in the supplied business evidence.

RadNet competes on center location, reputation, service quality, technologists, relationships with healthcare providers and referring physicians, and the availability of several imaging types at many centers. It says its regional networks allow centers to coordinate appointment calendars and move staff or equipment between locations. The company also believes its fees are generally lower than hospital fees for the same services.

Our reading: Regional density and referral relationships are a meaningful competitive advantage because they help RadNet offer convenient locations and coordinate capacity, but those relationships must be maintained locally. Our reading: Offering several imaging types at most centers supports convenience for physicians and patients, although hospitals and other operators also provide imaging services.

RadNet’s Digital Health products are used both within its centers and by outside providers. Its portfolio includes clinical AI, imaging software and workflow tools. Our reading: The combination of an operating imaging network and software gives RadNet opportunities to develop and deploy tools in its own workflows, but adoption by external customers and competition from other technologies remain important tests.

Growth opportunities

RadNet seeks to grow its imaging business by increasing scan volume at existing centers, adding or upgrading equipment, opening centers, acquiring operators and expanding joint ventures. Its strategy includes strengthening existing markets and entering areas where it sees demand, referral relationships and receptive payors. The company believes an aging population and greater use of preventive screening will increase demand for diagnostic imaging.

For the second quarter of 2026, same-center advanced imaging procedural volumes increased 9.6% compared with the prior-year quarter. RadNet has attributed capacity growth in part to faster MRI scanners, remote technologists and operational changes. It also faces backlogs in many markets and is building centers and adding equipment to increase capacity.

Digital Health’s growth plans include selling more products to existing customers, expanding internationally and adding clinical and operational applications. Its breast ultrasound AI solution received FDA clearance and is commercially available in the United States. RadNet plans to implement it across its network by year-end. The company is also deploying acquired Gleamer X-ray AI in several regions and cross-selling the Gleamer and DeepHealth portfolios.

RadNet has agreed to acquire ONRAD, with closing expected in early 2027 subject to conditions. Upon closing, ONRAD would form the foundation of a third reportable segment for radiology professional services. RadNet expects to introduce additional DeepHealth capabilities at ONRAD throughout 2027.

Revenue by fiscal year
  1. $1.3BFY2021
  2. $1.4BFY2022
  3. $1.6BFY2023
  4. $1.8BFY2024
  5. $2.0BFY2025

Structural risks

  • Reimbursement: Lower government or other payor rates can reduce revenue and margins per procedure. RadNet generally cannot recover higher costs from government programs simply by raising its fees, and commercial rates are negotiated.
  • Fixed costs and financing: Imaging requires substantial investment in facilities and equipment. Lower scan volumes can hurt profitability, while debt payments and credit-agreement restrictions can limit cash available for investment and other purposes.
  • Staffing and capacity: Shortages of technologists and radiologists have put pressure on salaries. RadNet has said lengthy backlogs can cause patients and referral sources to turn to competitors.
  • Healthcare regulation: Centers, contracted practices and physicians must comply with licensing, billing, privacy, anti-kickback and physician-referral rules. Violations can lead to penalties, repayment obligations or exclusion from government programs.
  • Technology and AI: Cyberattacks, outages and data loss can interrupt information systems. Commercial success for AI products also depends on regulatory clearances, effectiveness and acceptance by patients and providers.
  • Acquisition integration: RadNet must integrate acquired operations and retain personnel. Digital Health implementations and staff training also carry costs, and acquired businesses can affect margins during integration.

Bottom line

Our reading

Our reading: RadNet combines a capital-intensive imaging network with a software business that serves both its own centers and outside providers. Regional density, physician relationships and hospital partnerships support the imaging model, while Digital Health gives the company another way to participate in radiology workflows. Its growth depends on adding capacity and deploying technology without losing sight of reimbursement, staffing, integration and regulatory pressures.